The trajectory of Viagra presents a challenging picture for shareholders. While the initial introduction generated massive gains, the end of its patent opened the avenue to off-brand versions, dramatically reducing https://gorillasocialwork.com/story27513036/the-copyright-and-big-pharma-a-risky-investment